Advanced age should not preclude sunitinib use for mRCC

Elderly kidney cancer patients benefit from sunitinib therapy just as much as their younger counterparts, a retrospective analysis of six clinical trials shows.
Source: MedWire News - Oncology - Category: Cancer & Oncology Source Type: news